uniQure N.V. (QURE) stock
QURENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30224% above fair value
$20.78−1.10 (-5.03%)
Close on Nov 17, 2026Market cap $1.44BP/E –Yield –
uniQure operating margin
Operating margin is operating income as a percentage of revenue.
uniQure's operating margin for the twelve months ending Jun 30, 2026 was -1071.5%. For fiscal 2025 it was -1151.4%, against -679.6% the year before. The highest annual figure on record is 59.3% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1151.4% | −471.8 |
| FY2024 | Dec 31, 2024 | -679.6% | +1105.9 |
| FY2023 | Dec 31, 2023 | -1785.5% | −1651.0 |
| FY2022 | Dec 31, 2022 | -134.4% | −193.7 |
| FY2021 | Dec 31, 2021 | 59.3% | +393.6 |
| FY2020 | Dec 31, 2020 | -334.3% | +1329.4 |
| FY2019 | Dec 31, 2019 | -1663.8% | −881.9 |
| FY2018 | Dec 31, 2018 | -781.9% | −237.6 |
| FY2017 | Dec 31, 2017 | -544.3% | −257.7 |
| FY2016 | Dec 31, 2016 | -286.7% | +386.0 |
| FY2015 | Dec 31, 2015 | -672.6% | +201.5 |
| FY2014 | Dec 31, 2014 | -874.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -893.7% | −60.1 |
| Q1 FY2026 | Mar 31, 2026 | -1283.5% | +1226.4 |
| Q4 FY2025 | Dec 31, 2025 | -918.1% | −40.3 |
| Q3 FY2025 | Sep 30, 2025 | -1379.0% | +380.0 |
| Q2 FY2025 | Jun 30, 2025 | -833.6% | −438.1 |
| Q1 FY2025 | Mar 31, 2025 | -2510.0% | −1870.9 |
| Q4 FY2024 | Dec 31, 2024 | -877.8% | +45.4 |
| Q3 FY2024 | Sep 30, 2024 | -1759.0% | +4060.3 |
| Q2 FY2024 | Jun 30, 2024 | -395.6% | +2291.2 |
| Q1 FY2024 | Mar 31, 2024 | -639.1% | +753.8 |
| Q4 FY2023 | Dec 31, 2023 | -923.1% | −948.9 |
| Q3 FY2023 | Sep 30, 2023 | -5819.3% | −1711.7 |
| Q2 FY2023 | Jun 30, 2023 | -2686.8% | +8593.1 |
| Q1 FY2023 | Mar 31, 2023 | -1392.9% | +1625.0 |
| Q4 FY2022 | Dec 31, 2022 | 25.8% | +22.2 |
| Q3 FY2022 | Sep 30, 2022 | -4107.5% | −1845.1 |
| Q2 FY2022 | Jun 30, 2022 | -11279.9% | −11365.7 |
| Q1 FY2022 | Mar 31, 2022 | -3017.9% | +6774.7 |
| Q4 FY2021 | Dec 31, 2021 | 3.6% | +27.8 |
| Q3 FY2021 | Sep 30, 2021 | -2262.4% | +224.4 |
| Q2 FY2021 | Jun 30, 2021 | 85.8% | +2574.9 |
| Q1 FY2021 | Mar 31, 2021 | -9792.5% | +23345.0 |
| Q4 FY2020 | Dec 31, 2020 | -24.2% | +1232.1 |
| Q3 FY2020 | Sep 30, 2020 | -2486.9% | +508.0 |
| Q2 FY2020 | Jun 30, 2020 | -2489.1% | −1303.6 |
| Q1 FY2020 | Mar 31, 2020 | -33137.5% | −30716.4 |
| Q4 FY2019 | Dec 31, 2019 | -1256.3% | +249.0 |
| Q3 FY2019 | Sep 30, 2019 | -2994.8% | −2257.1 |
| Q2 FY2019 | Jun 30, 2019 | -1185.6% | −490.4 |
| Q1 FY2019 | Mar 31, 2019 | -2421.1% | −1857.6 |
| Q4 FY2018 | Dec 31, 2018 | -1505.3% | −629.0 |
| Q3 FY2018 | Sep 30, 2018 | -737.7% | −327.3 |
| Q2 FY2018 | Jun 30, 2018 | -695.2% | −296.4 |
| Q1 FY2018 | Mar 31, 2018 | -563.5% | +30.1 |
| Q4 FY2017 | Dec 31, 2017 | -876.4% | −696.8 |
| Q3 FY2017 | Sep 30, 2017 | -410.4% | −214.3 |
| Q2 FY2017 | Jun 30, 2017 | -398.8% | – |
| Q1 FY2017 | Mar 31, 2017 | -593.6% | – |
| Q4 FY2016 | Dec 31, 2016 | -179.5% | – |
| Q3 FY2016 | Sep 30, 2016 | -196.1% | – |
See a number that looks wrong?